Introduction: The antibacterial activity of metal-based nanoparticles (MBNPs) varies considerably even among materials with the same elemental composition. Differences in particle size, morphology, surface properties, aggregation, synthesis, and exposure conditions can alter nanoparticle–bacteria interactions and complicate comparisons between studies.
Aim: This review explores the principal physicochemical and experimental factors that determine the antibacterial performance of MBNPs and considers how these variables influence the interpretation and reproducibility of antibacterial studies.
Materials and Methods: A narrative literature review was conducted using Scopus, Web of Science, and PubMed. Studies addressing the relationship between MBNP characteristics or experimental conditions and antibacterial activity were considered.
Results and Conclusion: Antibacterial performance is determined by a combination of particle-related, biological, and experimental variables rather than nanoparticle composition alone. Smaller particle dimensions can increase available surface area and modify dissolution and surface reactivity, while morphology and surface chemistry influence bacterial contact and interfacial processes. Surface coatings can either restrict or enhance biological interactions, and aggregation may substantially change the effective particle size during antibacterial testing. Concentration, dissolution and metal-ion release, pH, ionic strength, proteins, organic matter, and light exposure further modify nanoparticle behavior. Differences in bacterial strain, growth state, inoculum, and assay methodology introduce additional variability and may contribute to apparently contradictory findings between studies. The antibacterial activity of MBNPs should be interpreted as the outcome of an interacting set of material and experimental variables rather than as a fixed property of a particular metal or metal oxide. Improved physicochemical characterization and more transparent reporting of microbiological test conditions are necessary for meaningful comparison between studies. Establishing reproducible relationships between nanoparticle characteristics and antibacterial performance will be important for the rational development of MBNP-based antimicrobial systems.
Franco D, Calabrese G, Guglielmino SPP, Conoci S. Metal-based nanoparticles: antibacterial mechanisms and biomedical application. Microorganisms. 2022;10(9):1778. doi: 10.3390/microorganisms10091778.
Wahab S, Salman A, Khan Z, Khan S, Krishnaraj C, Yun SI. Metallic nanoparticles: a promising arsenal against antimicrobial resistance—unraveling mechanisms and enhancing medication efficacy. Int J Mol Sci. 2023;24(19):14897. doi: 10.3390/ijms241914897.
Gautam S, Das DK, Kaur J, Kumar A, Ubaidullah M, Hasan M, et al. Transition metal-based nanoparticles as potential antimicrobial agents: recent advancements, mechanistic, challenges, and future prospects. Discov Nano. 2023;18(1):84. doi: 10.1186/s11671-023-03861-1.
Mammari N, Lamouroux E, Boudier A, Duval RE. Current knowledge on the oxidative-stress-mediated antimicrobial properties of metal-based nanoparticles. Microorganisms. 2022;10(2):437. doi: 10.3390/microorganisms10020437.
Liao Y, Wang X, Chen P, Zhong Q, Gong J. Antimicrobial mechanisms of metal-based nanomaterials. Int J Nanomedicine. 2025;20:12879-87. doi: 10.2147/IJN.S557649.
Menichetti A, Mavridi-Printezi A, Mordini D, Montalti M. Effect of size, shape and surface functionalization on the antibacterial activity of silver nanoparticles. J Funct Biomater. 2023;14(5):244. doi: 10.3390/jfb14050244.
Krychowiak-Maśnicka M, Wojciechowska WP, Bogaj K, Bielicka-Giełdoń A, Czechowska E, Ziąbka M, et al. The substantial role of cell and nanoparticle surface properties in the antibacterial potential of spherical silver nanoparticles. Nanotechnol Sci Appl. 2024;17:227-46. doi: 10.2147/NSA.S489407.
Ivanova N, Andonova V, Jelev I, Dimova G. Synthesis of silver nanoparticles with green tea-extracted reductants: a preliminary study for optimization of the preparation technique. Scr Sci Pharm. 2021;8(2):17-26. doi: 10.14748/ssp.v8i2.8453.
Caron AJ, Ali IJ, Delgado MJ, Johnson D, Reeks JM, Strzhemechny YM, et al. Zinc oxide nanoparticles mediate bacterial toxicity in Mueller-Hinton Broth via Zn²⁺. Front Microbiol. 2024;15:1394078. doi: 10.3389/fmicb.2024.1394078.
Algadi H, Alhoot MA, Al-Maleki AR, Purwitasari N. Effects of metal and metal oxide nanoparticles against biofilm-forming bacteria: a systematic review. J Microbiol Biotechnol. 2024;34(9):1748-56. doi: 10.4014/jmb.2403.03029.
El-Habib I, Maatouk H, Lemarchand A, Dine S, Roynette A, Mielcarek C, et al. Antibacterial size effect of ZnO nanoparticles and their role as additives in emulsion waterborne paint. J Funct Biomater. 2024;15(7):195. doi: 10.3390/jfb15070195.
Helmlinger J, Sengstock C, Groß-Heitfeld C, Mayer C, Schildhauer TA, Köller M, et al. Silver nanoparticles with different size and shape: equal cytotoxicity, but different antibacterial effects. RSC Adv. 2016;6(22):18490-501. doi: 10.1039/C5RA27836H.
Alshareef A, Laird K, Cross RBM. Shape-dependent antibacterial activity of silver nanoparticles on Escherichia coli and Enterococcus faecium bacterium. Appl Surf Sci. 2017;424:310-5. doi: 10.1016/j.apsusc.2017.03.176.
Khalifa HO, Oreiby A, Mohammed T, Abdelhamid MAA, Sholkamy EN, Hashem H, et al. Silver nanoparticles as next-generation antimicrobial agents: mechanisms, challenges, and innovations against multidrug-resistant bacteria. Front Cell Infect Microbiol. 2025;15:1599113. doi: 10.3389/fcimb.2025.1599113.
Modi SK, Gaur S, Sengupta M, Singh MS. Mechanistic insights into nanoparticle surface-bacterial membrane interactions in overcoming antibiotic resistance. Front Microbiol. 2023;14:1135579. doi: 10.3389/fmicb.2023.1135579.
Balog S, de Almeida MS, Taladriz-Blanco P, Rothen-Rutishauser B, Petri-Fink A. Does the surface charge of the nanoparticles drive nanoparticle-cell membrane interactions? Curr Opin Biotechnol. 2024;87:103128. doi: 10.1016/j.copbio.2024.103128.
Xue Y, Wang C, Zhao Y, Zhao Z, Cui R, Du B, et al. Mixed-charge hyperbranched polymer nanoparticles with selective antibacterial action for fighting antimicrobial resistance. Acta Biomater. 2024;189:545-58. doi: 10.1016/j.actbio.2024.08.044.
Timoszyk A, Grochowalska R. Mechanism and antibacterial activity of gold nanoparticles (AuNPs) functionalized with natural compounds from plants. Pharmaceutics. 2022;14(12):2599. doi: 10.3390/pharmaceutics14122599.
Ge P, Zhang J, Ding T, Xianyu Y. Surface chemistry of gold nanoparticles for bacterial detection and antimicrobial applications. ACS Mater Lett. 2023;5(3):638-55. doi: 10.1021/acsmaterialslett.2c00923.
Ivanova N, Ermenlieva N, Simeonova L, Kolev I, Slavov I, Karashanova D, et al. Chlorhexidine-silver nanoparticle conjugation leading to antimicrobial synergism but enhanced cytotoxicity. Pharmaceutics. 2023;15(9):2298. doi: 10.3390/pharmaceutics15092298.
Gudkov SV, Burmistrov DE, Fomina PA, Validov SZ, Kozlov VA. Antibacterial properties of copper oxide nanoparticles (review). Int J Mol Sci. 2024;25(21):11563. doi: 10.3390/ijms252111563.
Rodrigues AS, Batista JGS, Rodrigues MÁV, Thipe VC, Minarini LAR, Lopes PS, et al. Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics. Front Microbiol. 2024;15:1440065. doi: 10.3389/fmicb.2024.1440065.
Godoy-Gallardo M, Eckhard U, Delgado LM, de Roo Puente YJD, Hoyos-Nogués M, Gil FJ, et al. Antibacterial approaches in tissue engineering using metal ions and nanoparticles: from mechanisms to applications. Bioact Mater. 2021;6(12):4470-90. doi: 10.1016/j.bioactmat.2021.04.033.
Woźniak-Budych MJ, Staszak K, Staszak M. Copper and copper-based nanoparticles in medicine—perspectives and challenges. Molecules. 2023;28(18):6687. doi: 10.3390/molecules28186687.
El-Saadony MT, Fang G, Yan S, Alkafaas SS, El Nasharty MA, Khedr SA, et al. Green synthesis of zinc oxide nanoparticles: preparation, characterization, and biomedical applications—a review. Int J Nanomedicine. 2024;19:12889-937. doi: 10.2147/IJN.S487188.
Vanlalveni C, Ralte V, Zohmingliana H, Das S, Anal JMH, Lallianrawna S, et al. A review of microbes mediated biosynthesis of silver nanoparticles and their enhanced antimicrobial activities. Heliyon. 2024;10(11):e32333. doi: 10.1016/j.heliyon.2024.e32333.
Irede EL, Awoyemi RF, Owolabi B, Aworinde OR, Kajola RO, Hazeez A, et al. Cutting-edge developments in zinc oxide nanoparticles: synthesis and applications for enhanced antimicrobial and UV protection in healthcare solutions. RSC Adv. 2024;14(29):20992-21034. doi: 10.1039/D4RA02452D.
Ahmad I, Alshahrani MY, Wahab S, Al-Harbi AI, Nisar N, Alraey Y, et al. Zinc oxide nanoparticle: an effective antibacterial agent against pathogenic bacterial isolates. J King Saud Univ Sci. 2022;34(5):102110. doi: 10.1016/j.jksus.2022.102110.
Morgan RN, Aboshanab KM. Green biologically synthesized metal nanoparticles: biological applications, optimizations and future prospects. Future Sci OA. 2024;10(1):FSO935. doi: 10.2144/fsoa-2023-0196.
Susanti D, Haris MS, Taher M, Khotib J. Natural products-based metallic nanoparticles as antimicrobial agents. Front Pharmacol. 2022;13:895616. doi: 10.3389/fphar.2022.895616.
Serov DA, Gritsaeva AV, Yanbaev FM, Simakin AV, Gudkov SV. Review of antimicrobial properties of titanium dioxide nanoparticles. Int J Mol Sci. 2024;25(19):10519. doi: 10.3390/ijms251910519.
Önal Acet B, Gül D, Stauber RH, Odabaşı M, Acet Ö. A review for uncovering the “protein-nanoparticle alliance”: implications of the protein corona for biomedical applications. Nanomaterials (Basel). 2024;14(10):823. doi: 10.3390/nano14100823.
Guglielmelli A, D’Aquila P, Palermo G, Dell’Aglio M, Passarino G, Strangi G, et al. Role of the human serum albumin protein corona in the antimicrobial and photothermal activity of metallic nanoparticles against Escherichia coli bacteria. ACS Omega. 2023;8(34):31333-43. doi: 10.1021/acsomega.3c03774.
Schutte-Smith M, Erasmus E, Mogale R, Marogoa N, Jayiya A, Visser HG. Using visible light to activate antiviral and antimicrobial properties of TiO₂ nanoparticles in paints and coatings: focus on new developments for frequent-touch surfaces in hospitals. J Coat Technol Res. 2023;20(3):789-817. doi: 10.1007/s11998-022-00733-8.
Tzevelekidis P, Theodosiou M, Papadopoulou A, Sakellis E, Boukos N, Bikogiannakis AK, et al. Visible-light-activated antibacterial and antipollutant properties of biocompatible Cu-doped and Ag-decorated TiO₂ nanoparticles. Heliyon. 2024;10(17):e35634. doi: 10.1016/j.heliyon.2024.e35634.
Crisan MC, Pandrea SL, Matros L, Mocan T, Mocan L. In vitro antimicrobial activity of silver nanoparticles against selected Gram-negative and Gram-positive pathogens. Med Pharm Rep. 2024;97(3):280-97. doi: 10.15386/mpr-2750.
Aguilar-Garay R, Lara-Ortiz LF, Campos-López M, Gonzalez-Rodriguez DE, Gamboa-Lugo MM, Mendoza-Pérez JA, et al. A comprehensive review of silver and gold nanoparticles as effective antibacterial agents. Pharmaceuticals (Basel). 2024;17(9):1134. doi: 10.3390/ph17091134.
Chegini Z, Shariati A, Alikhani MY, Safaiee M, Rajaeih S, Arabestani M, et al. Antibacterial and antibiofilm activity of silver nanoparticles stabilized with C-phycocyanin against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus. Front Bioeng Biotechnol. 2024;12:1455385. doi: 10.3389/fbioe.2024.1455385.
Liu B, Liu D, Chen T, Wang X, Xiang H, Wang G, et al. iTRAQ-based quantitative proteomic analysis of the antibacterial mechanism of silver nanoparticles against multidrug-resistant Streptococcus suis. Front Microbiol. 2023;14:1293363. doi: 10.3389/fmicb.2023.1293363.
Liu HY, Prentice EL, Webber MA. Mechanisms of antimicrobial resistance in biofilms. NPJ Antimicrob Resist. 2024;2(1):27. doi: 10.1038/s44259-024-00046-3.
Mirghani R, Saba T, Khaliq H, Mitchell J, Do L, Chambi L, et al. Biofilms: formation, drug resistance and alternatives to conventional approaches. AIMS Microbiol. 2022;8(3):239-77. doi: 10.3934/microbiol.2022019.
Grooters KE, Ku JC, Richter DM, Krinock BA, Minor KA, Li P, et al. Strategies for combating antibiotic resistance in bacterial biofilms. Front Cell Infect Microbiol. 2024;14:1352273. doi: 10.3389/fcimb.2024.1352273.
Zhang X, Hou X, Ma L, Shi Y, Zhang D, Qu K. Analytical methods for assessing antimicrobial activity of nanomaterials in complex media: advances, challenges, and perspectives. J Nanobiotechnology. 2023;21(1):97. doi: 10.1186/s12951-023-01851-0.
Chung E, Ren G, Johnston I, Matharu RK, Ciric L, Walecka A, et al. Applied methods to assess the antimicrobial activity of metallic-based nanoparticles. Bioengineering (Basel). 2023;10(11):1259. doi: 10.3390/bioengineering10111259.
Faria M, Björnmalm M, Thurecht KJ, Kent SJ, Parton RG, Kavallaris M, et al. Minimum information reporting in bio-nano experimental literature. Nat Nanotechnol. 2018;13(9):777-85. doi: 10.1038/s41565-018-0246-4.
Janzadeh A, Behroozi Z, Saliminia F, Janzadeh N, Arzani H, Tanha K, et al. Neurotoxicity of silver nanoparticles in the animal brain: a systematic review and meta-analysis. Forensic Toxicol. 2022;40(1):49-63. doi: 10.1007/s11419-021-00589-4.